| 51 |
22473412 | Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study. | 2012 |
1 |
| 52 |
22582808 | Sfrp5 expression and secretion in adipocytes are up-regulated during differentiation and are negatively correlated with insulin resistance. | 2012 Sep |
1 |
| 53 |
22592687 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2012 May 16 |
1 |
| 54 |
22847059 | Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial. | 2012 Oct |
1 |
| 55 |
19233878 | A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats. | 2011 |
1 |
| 56 |
20356610 | What is the effect of rosiglitazone treatment on insulin secretory function in insulin-resistant individuals? It depends on how you measure it. | 2011 Jan |
9 |
| 57 |
20467418 | Rosiglitazone improves glucose metabolism in obese adolescents with impaired glucose tolerance: a pilot study. | 2011 Jan |
3 |
| 58 |
20682614 | Effect of glucose and insulin on oxidized low-density lipoprotein phagocytosis by human monocytes: a pilot study. | 2011 Feb |
1 |
| 59 |
20832829 | Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. | 2011 Jun |
1 |
| 60 |
20929990 | Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes Study. | 2011 Jan |
1 |
| 61 |
20943749 | FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction. | 2011 Jan |
1 |
| 62 |
20947819 | Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy. | 2011 Jan |
1 |
| 63 |
20971975 | Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL. | 2011 Jan |
1 |
| 64 |
21031343 | Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. | 2011 Feb |
1 |
| 65 |
21040499 | Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth. | 2011 Mar |
4 |
| 66 |
21167254 | Rosiglitazone balances insulin-induced exo- and endocytosis in single 3T3-L1 adipocytes. | 2011 Feb 10 |
5 |
| 67 |
21325466 | Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. | 2011 May |
2 |
| 68 |
21368750 | Preserved response to diuretics in rosiglitazone-treated subjects with insulin resistance: a randomized double-blind placebo-controlled crossover study. | 2011 Apr |
1 |
| 69 |
21415383 | Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. | 2011 May |
1 |
| 70 |
21424914 | The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. | 2011 Dec |
1 |
| 71 |
21430606 | Rosiglitazone treatment in nondiabetic subjects with nonalcoholic fatty liver disease. | 2011 Mar |
1 |
| 72 |
21463620 | A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues. | 2011 Jun 25 |
1 |
| 73 |
21559208 | Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin Resistance. | 2011 Apr 12 |
6 |
| 74 |
21576196 | Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin. | 2011 Jul |
2 |
| 75 |
21666815 | PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? | 2011 May 26 |
3 |
| 76 |
21672339 | Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study. | 2011 |
4 |
| 77 |
21709296 | Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. | 2011 Jul |
1 |
| 78 |
22028424 | Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease. | 2011 Nov |
1 |
| 79 |
22654727 | Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease. | 2011 Dec |
1 |
| 80 |
19556978 | Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. | 2010 Jan |
1 |
| 81 |
19765783 | Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle. | 2010 Feb |
1 |
| 82 |
19850645 | Rosiglitazone activation of PPARgamma suppresses fractalkine signaling. | 2010 Feb |
1 |
| 83 |
19911850 | The effects of rosiglitazone and high glucose on protein expression in endothelial cells. | 2010 Jan |
1 |
| 84 |
20026082 | Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling. | 2010 May 1 |
3 |
| 85 |
20091537 | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. | 2010 Jan 20 |
1 |
| 86 |
20105179 | Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney. | 2010 Feb 1 |
1 |
| 87 |
20121886 | The effect of rosiglitazone on insulin sensitivity and mid-thigh low-density muscle in patients with Type 2 diabetes. | 2010 Jan |
4 |
| 88 |
20158097 | [Anti-inflammatory effect of PPARgamma agonists: basics and clinical applications]. | 2010 Feb |
1 |
| 89 |
20158101 | [Protective role of PPARgamma agonists against cardiovascular disease]. | 2010 Feb |
1 |
| 90 |
20158105 | [Alzheimer's disease]. | 2010 Feb |
2 |
| 91 |
20191245 | Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. | 2010 Feb 19 |
1 |
| 92 |
20229808 | [Dementia and insulin resistance in patients with diabetes mellitus]. | 2010 Mar |
1 |
| 93 |
20415685 | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 May |
1 |
| 94 |
20499046 | Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage. | 2010 Sep |
2 |
| 95 |
20528570 | Thiazolinedione treatment in PCOS--an update. | 2010 Nov |
1 |
| 96 |
20573187 | The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. | 2010 Jun 23 |
1 |
| 97 |
20863714 | PPARγ in bone homeostasis. | 2010 Dec |
1 |
| 98 |
20923486 | Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20). | 2010 Sep |
1 |
| 99 |
21686295 | Impact of rosiglitazone meta-analysis on use of glucose-lowering medications. | 2010 |
1 |
| 100 |
18991162 | Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. | 2009 |
1 |